Entity Details

Primary name S19A3_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionQ9BZV2
EntryNameS19A3_HUMAN
FullNameThiamine transporter 2
TaxID9606
Evidenceevidence at protein level
Length496
SequenceStatuscomplete
DateCreated2006-04-18
DateModified2021-06-02

Ontological Relatives

GenesSLC19A3

GO terms

Show/Hide Table
GOName
GO:0005886 plasma membrane
GO:0015234 thiamine transmembrane transporter activity
GO:0016021 integral component of membrane
GO:0042723 thiamine-containing compound metabolic process
GO:0055085 transmembrane transport
GO:0071934 thiamine transmembrane transport

Subcellular Location

Show/Hide Table
Subcellular Location
Membrane

Domains

Show/Hide Table
DomainNameCategoryType
IPR002666 Reduced folate carrierFamilyFamily
IPR028337 Thiamine transporter 2FamilyFamily
IPR036259 MFS transporter superfamilyFamilyHomologous superfamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
607483 OMIMThiamine metabolism dysfunction syndrome 2, biotin- or thiamine-responsive type (THMD2)An autosomal recessive metabolic disorder characterized by episodic encephalopathy, often triggered by febrile illness, presenting as confusion, seizures, external ophthalmoplegia, dysphagia, and sometimes coma and death. If untreated, encephalopathies can result in permanent dystonia. Brain imaging may show characteristic bilateral lesions of the basal ganglia. The disease is caused by variants affecting the gene represented in this entry.

Drugs

Show/Hide Table
DrugNameSourceType
DB00152 ThiamineDrugbanksmall molecule